BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pinto M, Silva V, Barreiro S, Silva R, Remião F, Borges F, Fernandes C. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform. Ageing Res Rev 2022;79:101658. [PMID: 35660114 DOI: 10.1016/j.arr.2022.101658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Li S, Peng Y, Ma W, Wang Y, Li W. Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma. Cancer Innovation 2023. [DOI: 10.1002/cai2.59] [Reference Citation Analysis]
2 Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A. Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights. Brain Res Bull 2023;193:11-21. [PMID: 36435362 DOI: 10.1016/j.brainresbull.2022.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tian P, Liu W, Yang S, Zhang J. Amphiphilic drug slow release microspheres fabricated using polyvinyl alcohol, 10‐Undecen‐1‐ol , and multi‐walled carbon nanotubes. J of Applied Polymer Sci 2022. [DOI: 10.1002/app.53498] [Reference Citation Analysis]
4 Cetin Aluc C, Gok B, Kecel-gunduz S, Budama-kilinc Y. Glycyrrhizic acid Poly(D,L-lactide-co-glycolide) nanoparticles: anti-aging cosmeceutical formulation for topical applications. PeerJ 2022;10:e14139. [DOI: 10.7717/peerj.14139] [Reference Citation Analysis]